Akunah Reflect
Akunah Reflect is a medical device (FDA Class II) made by Akunah Pty, Ltd., cleared under FDA 510(k) K222987 on 10 May 2023 and listed in FDA GUDID since 25 Mar 2025 (UDI-DI 09309002093005), active as of 31 May 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number09309002093005 | Date25 Mar 2025 | StatusListed |
| United States | FDA 510(k)SESE | NumberK222987 | Date10 May 2023 | StatusActive |
Official records
- AccessGUDID record 09309002093005
- FDA 510(k) database K222987
From the FDA record
- Device description
- Akunah Reflect Planning Software
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K222987 decided 10 May 2023 Active
- FDA GUDID UDI-DI 09309002093005 listed 25 Mar 2025 Listed
Timeline
- Cleared FDA 510(k) K222987
- Listed FDA GUDID 09309002093005
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Generic name
- Orthopaedic/craniofacial implantation planning software
- Model / reference
- REFLECT
- Primary DI / UDI-DI
- 09309002093005
- 510(k) Number
- FDA product code
- QIH, LLZ
- GMDN term
- Orthopaedic/craniofacial implantation planning software
- Device class
- Class II
- Regulation number
- 892.2050
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Orthopaedic/craniofacial implantation planning software.